dTDP
Athanor · official
C10H16N2O11P2 · 402.19 g/mol
IUPAC name: [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate
Names and identifiers
- IUPAC name
- [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate
- Synonyms
- deoxy-TDP, Thymidine 5'-diphosphate, Thymidine 5'-pyrophosphate
+ 35 more
Deoxythymidine 5'-diphosphate, Thymidine 5'-(trihydrogen diphosphate), QQ3K1P45DF, DTXSID801027011, CHEBI:18075, {[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}phosphonic acid, ((hydroxy((((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl)methoxy))phosphoryl)oxy)phosphonic acid, RefChem:933037, DTXCID701511219, thymidine-5'-diphosphate, Thymidine diphosphate, thymidine-5'- diphosphate, 5'-TDP, [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate, ((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate, TYD, thymidine 5'-(trihydrogen diphosphate) (9CI), TDP (nucleotide), Thymidine Impurity 4, UNII-QQ3K1P45DF, 5-TDP, Mono(trihydrogen diphosphate), SCHEMBL154111, Thymidine pyrophosphate (6CI), CHEMBL259724, orb1983304, 2'-Deoxythymidine-5'-diphosphate, Thymidine 5'-pyrophosphate (7CI), Thymidine 5-(trihydrogen diphosphate), DB03103, Thymidine 5-(trihydrogen pyrophosphate), Thymidine 5a(2)-(trihydrogen diphosphate), NS00015202, C00363, Thymidine 5'-(trihydrogen pyrophosphate) (8CI)
- Molecular formula
- C10H16N2O11P2
- Empirical formula
- C10H16N2O11P2
- Molecular weight
- 402.19 g/mol
- Exact mass
- 402.02293
- CAS number
- 491-97-4
- PubChem CID
- 164628
- Canonical SMILES
- CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OP(=O)(O)O)O
- Isomeric SMILES
- CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O
- InChI
- InChI=1S/C10H16N2O11P2/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(22-8)4-21-25(19,20)23-24(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,11,14,15)(H2,16,17,18)/t6-,7+,8+/m0/s1
- InChIKey
- UJLXYODCHAELLY-XLPZGREQSA-N
- Molfile
Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.
Calculated
- Heavy atoms
- 25
- Rings
- 2
- Aromatic rings
- 1
- Fraction sp³ carbons (Fsp3)
- 0.6
- H-bond donors
- 5
- H-bond acceptors
- 8 computed here · PubChem 11
- Rotatable bonds
- 6
- TPSA (Ų)
- 197.6 computed here · PubChem 192
- Formal charge
- 0
- XLogP3
- -3.9 PubChem
- Complexity
- 688 PubChem
- Stereocenters
- 3 defined, 1 undefinedCIP: C5: R · C7: S · C9: R · P12: undefined
- Double-bond geometry
- None specified
- Point group
- C1 of one 3D conformer with its hydrogens, by Athanor’s engine (as in the app)
Elemental analysis
- C29.86%
- H4.01%
- N6.97%
- O43.76%
- P15.40%
Isotope pattern
Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.
Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.
Predicted
- log P
- -1.28 Crippen (Wildman and Crippen 1999)
- log S (water solubility)
- -1.31 ESOL (Delaney 2004), log mol/L
- Synthetic accessibility
- 4 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)
Drug-likeness: Lipinski’s rule of five
- Molecular weight ≤ 500: 402.19
- log P ≤ 5 (Crippen): -1.28
- H-bond donors ≤ 5: 5
- H-bond acceptors ≤ 10: 8
Passes all four rules.
¹³C NMR shifts, predicted
Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.
Safety
No GHS hazard classification was found in the sources.
Safety data sheets on the supplier’s page: InvivoChem, Smolecule, EvitaChem.
Always read the supplier’s safety data sheet before working with it.
Spectra
- 13C NMRSpectraBase
- 31P NMRSpectraBase
- MS-MSHuman Metabolome Database (HMDB) (LC-ESI-QTOF · negative)
- LC-MSMassBank Europe (impact II · LC-ESI-QTOF · NEGATIVE) · MassBank Europe (impact II · LC-ESI-QTOF · NEGATIVE) · MassBank Europe (impact II · LC-ESI-QTOF · NEGATIVE) · MassBank Europe (impact II · LC-ESI-QTOF · NEGATIVE) · MassBank Europe (impact II · LC-ESI-QTOF · NEGATIVE) · MassBank Europe (UPLC Q-Tof Premier, Waters · LC-ESI-QTOF · NEGATIVE)
- Other MSMassBank of North America (MoNA) (TQD, Waters · Flow-injection QqQ/MS · ESI) · MassBank of North America (MoNA) (TQD, Waters · Flow-injection QqQ/MS · ESI) · MassBank of North America (MoNA) (TQD, Waters · Flow-injection QqQ/MS · ESI)
Experimental spectra held by these sources; each link opens the source's own record.
Literature
Reading PubChem, OpenAlex and GSRS…
Bioactivity
Reading ChEMBL…
References
- [1]SpectraBase · Linked only · via PubChem · retrieved 2026-10-14
- [2]Human Metabolome Database (HMDB) · Linked only · via PubChem · retrieved 2026-10-14
- [3]MassBank Europe · Linked only · via PubChem · retrieved 2026-10-14
- [4]MassBank of North America (MoNA) · CC BY 4.0 · via PubChem · retrieved 2026-10-14
- ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
- ·Literature on PubChem
Data last updated 2026-10-14.
